Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Expands By 145.3%

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 67,700 shares, an increase of 145.3% from the March 31st total of 27,600 shares. Based on an average daily volume of 530,200 shares, the short-interest ratio is presently 0.1 days.

CV Sciences Stock Performance

Shares of OTCMKTS:CVSI opened at $0.04 on Friday. The firm has a market cap of $6.15 million, a PE ratio of 1.89 and a beta of 0.62. The firm’s 50 day simple moving average is $0.04 and its 200-day simple moving average is $0.04. CV Sciences has a one year low of $0.03 and a one year high of $0.06.

CV Sciences (OTCMKTS:CVSI) last issued its earnings results on Thursday, March 28th. The company reported ($0.01) EPS for the quarter. The company had revenue of $3.80 million for the quarter. CV Sciences had a return on equity of 80.98% and a net margin of 19.38%.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.